EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Post-dengue transverse myelitis: a challenging case of neurological and therapeutic evidence

Bianca Frigo Pires, Caroline Goulart Nunes de Souza, Eduardo Coviello Mendes de Campos, Talles Rajab, Mariana Ferreira de Albuquerque, João Victor Padovani do Carmo, Fernanda Ferraioli de Paula, Luiz Guilherme Peleckis, Bruno Tolentino Foroni, Clara Luisa Negraes Navarrete, Fernanda Goulart Nunes de Souza, Gustavo Henrique de Moura Vardasca, Natalia Seno Croccia, Raiza Marques Vieira Campos, Ruy Yoshiaki Okaji

Oxford Medical Case Reports · 2026-02-18 · 2026 (2) · 148-150

DOI: 10.1093/omcr/omag005 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction Dengue is an arbovirus with significant global prevalence that can lead to severe neurological complications, such as longitudinally extensive transverse myelitis (LEMT). Case report We describe a 36-year-old man who developed sudden paraparesis and urinary retention approximately ten days after dengue infection. MRI revealed longitudinal hyperintense lesions in the cervical and thoracic spinal cord. Cerebrospinal fluid analysis revealed an inflammatory pattern and dengue serology was positive. The patient was treated with intravenous methylprednisolone and rehabilitation, leading to gradual neurological improvement and functional recovery. Discussion Post-dengue transverse myelitis may result from parainfectious or post-infectious autoimmune mechanisms, often accompanied by demyelination and spinal cord inflammation. The low rate of DENV IgM in the CSF reinforces the immune-mediated hypothesis. Prognosis varies depending on the early intervention and the extent of spinal injury. Underreporting remains a challenge, and future studies should explore biomarkers and develop standardized management protocols.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →